气相色谱-质谱联用法测定维生素C泡腾片中的甜蜜素

采用气相色谱-质谱(GC-MS)选择离子监测法(SIM),建立了准确可靠、灵敏度高、快速简便的测定维生素C泡腾片中甜蜜素含量的新方法.样品中的甜蜜素衍生后用有机试剂提取,在选择离子模式下进行测定,以保留时间和特征离子比例进行定性,单离子定量.甜蜜素的线性范围为0.05-10mg/L,检出限为0.6mg/kg,回收率为90.5%-96.9%,相对标准偏差小于4.4%.方法分析所用时间短,结果准确可靠,选择性好,适用于维生素C泡腾片中甜蜜素含量的检验.     

Voltammetric behaviour of bromhexine and its determination in pharmaceuticals

A complete electrochemical study and a novel electroanalytical procedure for bromhexine quantitation are described. Bromhexine in methanol/0.1 mol L⁻¹ Britton–Robinson buffer solution (2.5/97.5) shows an anodic response on glassy carbon electrode between pH 2 and 7.5. By DPV and CV, both peak potential and current peak values were pH-dependent in all the pH range studied. A break at pH 5.5 in E_P versus pH plot revealing a protonation–deprotonation (pK_a) equilibrium of bromhexine was observed. Spectrophotometrically, an apparent pK_a value of 4.3 was also determined.

An electrodic mechanism involving the oxidation of bromhexine via two-electrons and two-protons was proposed. Controlled potential electrolysis followed by HPLC–UV and GC–MS permitted the identification of three oxidation products: N-methylcyclohexanamine, 2-amino-3,5-dibromobenzaldehyde and 2,4,8,10-tetrabromo dibenzo[b,f][1,5] diazocine.

DPV at pH 2 was selected as optimal pH for analytical purposes. Repeatability, reproducibility and selectivity parameters were adequate to quantify bromhexine in pharmaceutical forms. The recovery was 94.50 ± 2.03% and the detection and quantitation limits were 1.4 × 10⁻⁵ and 1.6 × 10⁻⁵ mol L⁻¹, respectively. Furthermore, the DPV method was applied successfully to individual tablet assay in order to verify the uniformity content of bromhexine. No special treatment of sample were required due to excipients do not interfered with the analytical signal. Finally the method was not time-consuming and less expensive than the HPLC one.     

Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry

Melatonin was determined in pharmaceutical preparations by means of two simple and reliable analytical methods based on micellar electrokinetic chromatography (MEKC) and spectrofluorimetry. The fluorescence emission values were measured at λ=350 nm when exciting at λ=275 nm. The MEKC analysis was achieved using a system consisting of 40 mM SDS in phosphate buffer (20 mM, pH 7.5). The extraction of melatonin from the tablets was achieved by means of a simple one-step dissolution with methanol/water. Both methods were applied for the determination of melatonin in commercial formulations and galenic preparations. The MEKC procedure allows the quantitative determination of melatonin in all pharmaceutical preparations tested. On the contrary, the spectrofluorimetric method is not suitable for tablets which also contain tryptophan; this interference can be eliminated by a suitable liquid-liquid extraction procedure. The results obtained with the two methods are in good agreement and satisfactory in terms of precision and accuracy.     

Development and Validation of Kinetic Spectrophotometric Method for the Determination of Losartan Potassium in Pure and Commercial Tablets

A validated kinetic spectrophotometric method has been developed for the determination of losartan potassium in pure and dosage forms. The method is based on oxidation of the losartan potassium with alkaline potassium permanganate at room temperature (25 ± 1 °C). The reaction is followed spectrophotometrically by measuring the increase in absorbance with time at 603 nm, and the initial rate, fixed time (at 12.0 min) and equilibrium time (at 90.0 min) methods are adopted for constructing the calibration graphs. All the calibration graphs are linear in the concentration range of 7.5–60.0 μg mL^?1 and the calibration data resulted in the linear regression equations of n? = ?6.422 × 10^?7 + 1.173 × 10^?5 C, A =3.30 × 10^?4 + 5.28 × 10^?3 C and A = ?2.09 × 10^?2 + 1.05 × 10^?1 C for initial‐rate, fixed time and equilibrium time methods, respectively. The limits of detection for initial rate, fixed time and equilibrium time methods are 0.71, 0.21 and 0.19 μg mL^?1, respectively. The activation parameters such as E_a, ΔH^?, ΔS^?, and ΔG^? are also determined for the reaction and found to be 87.34 KJ mol^?1, 84.86 KJ mol^?1, 50.96 JK^?1 mol^?1 and ?15.10 KJ mol^?1, respectively. The variables are optimized and the proposed methods are validated as per ICH guidelines. The method has been applied successfully to the estimation of losartan potassium in commercial tablets. The performance of the proposed methods was judged by calculating paired t‐ and F‐ values. The analytical results of the proposed methods when compared with those of the reference method show no significant difference in accuracy and precision and have acceptable bias.     

A highly sensitive LC–MS/MS method for simultaneous determination of glycyrrhizin and its active metabolite glycyrrhetinic acid: Application to a human pharmacokinetic study after oral administration

A highly sensitive liquid chromatography tandem mass spectrometry (LC–MS/MS) method for simultaneous determination of glycyrrhizin (GL) and its active metabolite, glycyrrhetinic acid (GA), from human plasma was validated and applied to a human pharmacokinetic study. The analytes were extracted from human plasma using an Oasis MAX cartridge and chromatographic separation was performed on an Inertsil ODS‐3 column. The detection was performed using an API 4000 mass spectrometer operating in the positive electrospray ionization mode. Selected ion monitoring transitions of m /z 823 → 453 for GL and m /z 471 → 149 for GA were obtained. The response was a linear function of concentration over the ranges of 0.5–200 ng/mL for GL and 2–800 ng/mL for GA (both R ² > 0.998). Using this method, the pharmacokinetics of GL after single oral administration of a clinical dose (75 mg) to six healthy male Japanese volunteers were evaluated. GL was detected in the plasma of all subjects and the average peak concentration was 24.8 ± 12.0 ng/mL. In contrast, peak concentration of GA was 200.3 ± 60.3 ng/mL, i.e. ~8‐fold higher than that of GL. This is the first report clarifying pharmacokinetic profiles of GL and GA simultaneously at a therapeutic oral dose of a GL preparation.     

微芯片毛细管电泳法快速测定盐酸二甲双胍

提出用带有非接触电导检测的微芯片毛细管电泳法快速测定片剂中盐酸二甲双胍的含量。取盐酸二甲双胍片20片,剥除糖衣后混匀研细,称取0.100 0g,用水超声溶解、过滤,滤液定容至100mL供毛细管电泳分析。十字通道芯片使用前按规定进行清洗。试验中采用含5%(体积分数)乙醇和0.1mmol·L-1十二烷基磺酸钠的2.0mmol·L-1柠檬酸缓冲溶液作为分离介质,进时间为10.0s,分离电压为1.3kV,可在1min内实现分离和测定。盐酸二甲双胍的质量浓度在10.0~110.0mg·L-1范围内与相应峰高呈线性关系,检出限(3S/N)为1.0mg·L-1。应用此方法分析了3个片剂样品,并用标准加入法做回收试验,测得回收率在94.5%~103%之间,测定值的相对标准偏差(n=6)在0.63%~1.1%之间。     

微乳液毛细管电动色谱法快速测定消炎利胆片中的穿心莲内酯和脱水穿心莲内酯

建立了微乳液毛细管电动色谱同时分析消炎利胆片中穿心莲内酯和脱水穿心莲内酯的方法。考察了缓冲溶液的浓度、pH值、十二烷基硫酸钠(SDS)以及助表面活性剂的含量对分离测定的影响。在由乙酸乙酯-SDS-正丁醇-30 mmol/L硼砂缓冲液(pH 9.5)（质量比为0.5∶0.6∶6.0∶92.9）组成的微乳液体系中,两种内酯在6 min内完成分离。该法简便、快速、选择性好,用于实际样品中穿心莲内酯和脱水穿心莲内酯的分析,获得了满意的结果。     

光纤过程检测硫酸亚铁缓释片释放度

建立光纤药物溶出度实时测定仪（FODT）在线监测硫酸亚铁溶出度测定的新方法.研究发现通过络合反应检测Fe2＋是可行的,FODT测定硫酸亚铁缓释片释放度与AAS测定结果无统计学意义.利用FODT过程检测硫酸亚铁缓释片释放度,全面直观地反映了药品的释放过程和内在质量,较经典方法能提供更多信息,测定过程简便自动,测定结果准确可靠.     

安胃片质量标准研究

对安胃片进行质量标准研究。采用薄层色谱法对安胃片中延胡索进行鉴别,并且采用高效液相色谱法对其中的延胡索乙素进行含量测定。色谱柱为Kromasil C18色谱柱（4.6mm×150mm,5μm）,流动相为甲醇-水（三乙胺调pH值为8.68,V：V=65：35）,检测波长为280nm,流速1.0mL/min,柱温为室温。结果显示在薄层色谱中均可检出延胡索特征斑点;延胡索乙素在0.18—1.47μg范围内线性关系良好,r=0.9999,平均加样回收率为97.49%（RSD=1.64%,n=6）。本方法简便可行、重复性好,能有效控制该制剂的质量。     

缓释片中新斯的明的含量测定

采用紫外分光光度法测定新斯的明缓释片中新斯的明的含量及对其稳定性进行研究。结果表明,新斯的明浓度在80—560μg.mL-1范围内与吸光度呈良好的线性关系,回归方程为：A=0.0016C-0.0089,r=0.9999;平均回收率为100.46%,RSD为0.89%（n=9）。该法简便、快速,重现性好,结果准确可靠。